Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mucocutaneous Manifestations of Patients With Chronic Kidney Disease Under Hemodialysis: A Cross-Sectional Study of 49 Patients Publisher Pubmed



Tajalli F1 ; Mirahmadi SMS2 ; Mozafarpoor S3 ; Goodarzi A4 ; Nasiri Partovi M5 ; Lakestani D6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Urology, Firoozabadi Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Department of General Medicine, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
  3. 3. Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Dermatology, Rasool Akram Medical Complex, Iran University of Medical Sciences (IUMS), Tehran, Iran
  5. 5. Department of Radiology, Rasool Akram Medical Complex, Iran University of Medical Sciences (IUMS), Tehran, Iran
  6. 6. Pediatric Department, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Dermatologic Therapy Published:2021


Abstract

Chronic kidney disease (CKD) is a common medical problem with well-known dermatologic manifestations, some of which highly disturb the patients' quality of life. This cross-sectional study was designed to identify the prevalence and type of cutaneous involvement in CKD patients. The skin manifestations of 49 patients with CKD undergoing hemodialysis at Akhavan Hospital in Kashan, Iran, were recorded over 2 months. Diabetes (35%) was the most common cause of chronic renal failure in the patients, and the most common skin manifestations were xerosis (95.9%), uremic pigmentation (89.8%), scleral discoloration (87.8%), dental discoloration (85.2% among the patients with natural teeth), dry mouth (65.3%), varicosity (61.2%), pruritus (57.1%), skin atrophy (49%), lentigo (46.9%), subungual hyperkeratosis (42.9%), half and half nail dystrophy (34.7%), and purpura (26.5%). Mucocutaneous involvement has a very high prevalence in CKD patients undergoing hemodialysis, and some of the cases are medically and cosmetically disturbing; therefore, with better knowledge about the type and prevalence of these involvements, the consequences can be better predicted and managed. Further studies are recommended to be conducted on the association between these signs and CKD grade, and clinical trials are also required for establishing the treatment options available for these signs and then assessing the patients' quality of life as a primary outcome measure. © 2021 Wiley Periodicals LLC.
Other Related Docs